Ventas (NYSE:VTR) Director Michael Embler Acquires 2,500 Shares

Ventas, Inc. (NYSE:VTR) Director Michael Embler acquired 2,500 shares of the stock in a transaction dated Wednesday, June 3rd. The stock was bought at an average cost of $78.81 per share, with a total value of $197,025.00. Following the completion of the purchase, the director directly owned 19,202 shares in the company, valued at approximately $1,513,309.62. The trade was a 14.97% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link.

Ventas Trading Up 3.8%

Shares of NYSE:VTR traded up $3.03 during trading on Friday, hitting $82.13. The company had a trading volume of 3,615,209 shares, compared to its average volume of 3,599,845. The stock has a market cap of $39.93 billion, a price-to-earnings ratio of 149.33, a price-to-earnings-growth ratio of 1.74 and a beta of 0.71. Ventas, Inc. has a one year low of $61.76 and a one year high of $91.06. The company has a fifty day simple moving average of $85.06 and a two-hundred day simple moving average of $82.36. The company has a debt-to-equity ratio of 0.95, a current ratio of 0.25 and a quick ratio of 0.25.

Ventas (NYSE:VTR) last posted its quarterly earnings data on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.01). Ventas had a return on equity of 2.09% and a net margin of 4.25%.The firm had revenue of $1.65 billion during the quarter, compared to analysts’ expectations of $1.59 billion. During the same period last year, the company earned $0.84 earnings per share. The business’s revenue for the quarter was up 22.0% compared to the same quarter last year. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. As a group, equities analysts forecast that Ventas, Inc. will post 3.88 earnings per share for the current year.

Ventas Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, July 16th. Stockholders of record on Tuesday, June 30th will be issued a $0.52 dividend. This represents a $2.08 annualized dividend and a dividend yield of 2.5%. The ex-dividend date is Tuesday, June 30th. Ventas’s dividend payout ratio is presently 378.18%.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on the company. JPMorgan Chase & Co. increased their price target on Ventas from $93.00 to $94.00 and gave the stock an “overweight” rating in a report on Monday, May 11th. BMO Capital Markets reiterated an “outperform” rating and issued a $100.00 price target on shares of Ventas in a report on Monday, May 4th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $93.00 price target on shares of Ventas in a report on Monday, February 9th. Evercore reiterated an “outperform” rating and issued a $95.00 price target on shares of Ventas in a report on Wednesday, April 29th. Finally, Weiss Ratings reiterated a “buy (b-)” rating on shares of Ventas in a report on Friday, March 27th. Fourteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $95.19.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the company. Dynamic Wealth Strategies LLC purchased a new position in Ventas during the 1st quarter worth $25,000. GoalVest Advisory LLC purchased a new position in Ventas during the 4th quarter worth $26,000. Wiser Advisor Group LLC purchased a new position in Ventas during the 3rd quarter worth $27,000. IFC & Insurance Marketing Inc. purchased a new position in Ventas during the 4th quarter worth $30,000. Finally, Elyxium Wealth LLC purchased a new position in Ventas during the 4th quarter worth $33,000. 94.18% of the stock is currently owned by hedge funds and other institutional investors.

About Ventas

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.